PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Christopher E M Griffiths Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

09/2008	Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine.
09/2008	Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis.
08/2008	Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis.
05/2008	Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.
02/2008	Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.
09/2007	Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.
08/2007	Filaggrin null alleles are not associated with psoriasis.
06/2007	Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis.
08/2006	Infliximab for the treatment of psoriasis.
04/2006	Biological therapy for psoriasis.
02/2006	Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis.
01/2006	A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
10/2005	Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.
01/2004	Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset.
06/2003	An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.
06/2003	Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy.
01/2002	Immunotherapy for psoriasis: from serendipity to selectivity.

Articles by Research Topic

Disease

17	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2008 - 01/2002
1	Nail Diseases (Nail Disease) 02/2008
1	Keratosis 07/2003

Drug/Important Bio-Agent (IBA)

4	infliximab (Remicade)FDA Link 02/2008 - 10/2005
2	Methotrexate (Mexate)FDA LinkGeneric 09/2008 - 08/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2006 - 01/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2008
1	squamous cell carcinoma-related antigenIBA 09/2008
1	RetinoidsIBA 09/2008
1	filaggrinIBA 08/2007
1	Proteins (Proteins, Gene)IBA 06/2007
1	Immunoglobulin G (IgG)IBA 06/2007
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2006
1	adapalene (Differin)FDA Link 07/2003
1	alefacept (Amevive)FDA Link 06/2003

Therapy/Procedure

2	Biological Therapy 05/2008 - 04/2006
1	Photochemotherapy (Photodynamic Therapy) 06/2003
1	Immunotherapy 01/2002